Quercetin, a bioflavonoid, reverses development of tolerance and dependence to morphine

Drug Development Research

Volumn 57, Issue 4, 2002, Pages 167-172

  Singh, Amanpreet ^a   Naidu, Pattipati S ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Dependence; GIT transit; Morphine; Naloxone; Quercetin; Tolerance

Indexed keywords

BIOFLAVONOID; MORPHINE; NALOXONE; QUERCETIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRANSIT; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; TAIL FLICK TEST; WITHDRAWAL SYNDROME;

EID: 0037000393     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10119     Document Type: Article

References (29)

1. Bhargava HN. 1994. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behaviour. Pharmacol Rev 46:293-324.
2. Blasig J, Herz A, Reinhold K, Zieglgansberger S. 1973. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19-38.
3. Bronner C, Landry Y. 1985. Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions 16:147-151.
4. Cappaso A. 2001. Involvement of nuclear factor-κ B in the expression of opiate withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 25:1259-1268.
5. Cappaso A, Piacente S, Pizza C, Sorrentino L. 1998. Flavonoids reduce morphine withdrawal in-vitro. J Pharm Pharmacol 50: 561-564.
6. Chen YC, Shen SC, Lee WR, Hou, WC, Yang LL, Lee TJ. 2001. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expression by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J Cell Biochem 82:537-548.
7. Cuellar B, Fernandez AP, Lizasoain I, Moro MA, Lorenzo P, Bentura ML, Rodrigo J, Leza JC. 2000. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmcology 148:66-73.
8. Dambisya YM, Lee TL. 1996. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 117:914-918.
9. De Whalley CV, Rankin JF, Rankin SM, et al. 1990. Flavonoids inhibit the oxidative modification of low-density lipoproteins. Biochem Pharmacol 39:1743-1749.
10. El-Gawad A, Khalifa AE. 2001. Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain. Pharmacol Res 43:257-263.
11. Fiorani M, De Sanctis R, Menghinello P, Cucchiarini L, Cellini B, Dacha M. Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells. Free Rad Res 34: 639-648.
12. Johnson MA, Hill RG, Hughes J. 1988. A possible role for prostaglandins in the expression of morphine dependence in guinea pig isolated ileum. Br J Pharmacol 93:932-936.
13. Kaul TN, Middleton E Jr, Ogra PL. 1985. Antiviral effect of flavonoids on human viruses. J Med Virol 15:71-79.
14. Kulkarni SK, Ninan I. 1997. Inhibition of morphine tolerance and dependence by Withania somnifera in mice. J Ethnopharmacol 57:213-217.
15. Kulkarni SK, Verma A. 1992. Prevention of development of tolerance and dependence to opiate in mice by BR-16A (Mentat®). Ind J Exp Biol 30:885-888.
16. Leu WM, Su MT, Lin WB, Tao PL. 1999. The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices. Eur J Pharmacol 383:129-135.
17. Majeed NH, Przewlocka B, Machelska H, Przewlocka R. 1994. Inhibition of nitric oxide synthase attenuates the development of tolerance and dependence in mice. Neuropharmacology 33: 189-192.
18. Melzig MF, Pertz HH, Krenn L. 2001. Anti-inflammatory and spasmolytic activity of extracts from Droserae herba. Phytomedicine 8:225-229.
19. Miller AL. 1996. Antioxidant flavonoids: structure, function and clinical usage. Alt Med Rev 1:103-111.
20. Mu MM, Chakravortty D, Sugiyama T, Koide N, Takahashi K, Mori I, Yoshida T, Yokochi T. 2001. The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells. J Endotoxin Res 7:431-138.
21. Ninan I, Kulkarni SK. 2000. Ketanserin reverses dozocilpine-suppression of morphine dependence but not tolerance in mice. Brain Res 876:215-219.
22. Powell KJ, Hosokawa A, Bell A, Sutak M, Miline B, Quirion R, Jhamandas K. 1999. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol 127:631-644.
23. Puig MM, Pol O, Warner W. 1995. Peripheral effects of naloxone in mice with acute diarrhoea associated with intestinal inflammation. J Pharmacol Exp Ther 272:1271-1276.
24. Raghavendra V, Kulkarni SK. 2000. Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. Eur J Pharmacol 409:279-289.
25. Reddy DS, Kulkarni SK. 1997. Chronic neurosteroid treatment prevents development of morphine tolerance and attenuates abstinence behavior in mice. Eur J Pharmacol 337:19-25.
26. Saija A, Scalese M, Lanza M, et al. 1992. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol Med 19:481-486.
27. Scoto GM, Spadaro C, Spampinato S, Nossan N, Arrigo-Reina R, Ferri S. 1979. Prostaglandins in rat placenta following acute and chronic administration of morphine. Arch Toxicol Suppl 2: 375-380.
28. Vaccarino AL, Kastin AJ. 2001. Endogenous opiates: 2000. Peptides 22:2257-2328.
29. Vaupel DB, Kimes AS, London ED. 1995. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology 13:315-322.